Medicine & Life Sciences
Prostatic Neoplasms
100%
Prostate
47%
Biopsy
33%
Prostate-Specific Antigen
27%
Neoplasms
27%
Watchful Waiting
26%
Tetrahydrofolate Dehydrogenase
21%
Data Systems
20%
Urinary Bladder Neoplasms
17%
Image-Guided Biopsy
15%
Molecular Imaging
13%
Biomarkers
13%
Medical Overuse
12%
Telomere
12%
Magnetic Resonance Imaging
11%
Prostatectomy
11%
Transplants
11%
Methotrexate
11%
hyaluronan-mediated motility receptor
10%
Multiparametric Magnetic Resonance Imaging
10%
alpha-methylacyl-CoA racemase
10%
Urinary Bladder
9%
Trimetrexate
9%
African Americans
9%
Population
9%
ribose-5-phosphate
9%
Therapeutics
9%
Bone Marrow
9%
Prostate Cancer, Hereditary, 7
9%
Nucleosides
9%
Folic Acid Antagonists
8%
Racemases and Epimerases
8%
Bladder Exstrophy
8%
Decision Support Techniques
8%
Early Detection of Cancer
8%
Pharmaceutical Preparations
8%
Chromosomes, Human, Pair 14
7%
Transplant Recipients
7%
Microsatellite Repeats
7%
Genetic Markers
7%
Adenoviridae
7%
Cryosurgery
7%
Coenzyme A
7%
Dependovirus
7%
4-(3'-(2'-chlorophenyl)-2'-propen-1'-ylidene)-1-phenyl-3,5-pyrazolidinedione
6%
Kidney
6%
African Continental Ancestry Group
6%
Whole-Body Irradiation
6%
Prolapse
6%
Purkinje Cells
6%